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The Immunosuppressive Agent 1S-Deoxyspergualin Induces Tolerance 
and Modulates MHC-Antigen Expression and Interleukin-1 Production 
.in the Early Phase of Rat Allograft Responses 
~.M . Waaga, K. Ulrichs, M. Krzymanski, J. Treumer, M.L. Hansmann, T. Rommel, 
and W. MOller-Ruchholtz 
'T HE new immunosuppressant 15-deoxyspergualin 
(DOS) is approximately as effective as cyclosporin A 
t prolonging aUograft acceptance, but appears to act by a ~ifferent mechanism. The aim of thi study was to gain 
more insight into the possible mechanism(s) of DOS. The 
methods used for this purpose included kidney and skin 
grafting, immunoperoxidase histology , F ACS analysis, 
and tests of interleukin-I (lL-1) production. 
. RESULTS 
MHC fuUy allogeneic rat kidney grafts (Dark Agouti to 
Lewis) are accepted indefinitely when DOS (2.5 mg/kg/d 
IP) is applied from day 0 to day + 13. DOS induces specific, 
immunological tolerance , as shown by indefinitely ac-
cepted donor type and normally rejected third-party skin 
grafts on day + 150. 
A can be shown with MHC allogeneic kidney as well as 
skin grafts (normal survival periods , 7 to 9 days) , DOS is 
highly effective at prolonging graft survival (kidneys, > 250 
days; skin, 23 to 27 days), when treatment begins between 
days + I and + 3, but not between day +4 and + 6. 
Frozen tissue sections of surv iving kid neys (treatment 
beginning on day + I , + 2, or + 3) show a remarkable 
downregulation of MHC class I (M RC-OX 18) antigens, but 
not class II (MRC-OX6) antigens on various kidney cells 
(see Table I) . However, when treatment begins as late as 
day + 5, DOS fails to inhibit upregulation of class I 
antigens as shown by rejected kidneys. 
FACS analysis of LEW rats treated with DOS in vivo 
(2.5 mg/kg IP for 7 days) indicated that class I antigens are 
downregulated on splenic macrophages, but class II anti-
gens are not. This effect is dose dependent (2.5 to < 5.0 
mg/kg) . In contrast, the expression of cla s I antigens on B 
and T lymphocytes is unaltered. Furthermore, DOS in-
duces the appearance of a second population of MRC-
OX4 1 + peritoneal exudate macrophages as early as 24 
hours after treatment begins. This population, which is 
significantly poorer in MHC class I expression, reaches its 
maximum number of ceUs on the seventh day of treatment 
and disappears within 14 days after the last DOS applica-
tion. 
lL-I production by splenic and peritoneal exudate mac-
rophages treated in vitro with DOS is reduced ignificantly 
at lower DOS dosages (0.005-0.5 mg DOS/mL culture 
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Table 1. Influence of Timing of DOS Application on MHC Classes I and 11 Antigen Expression in Normal Rat Kidneys and Kidney AI-
lografts in the DA to LEW Strain Combination 
Antigen Expression 
Strain Corn· MHC Class I 
MHC Class 11 
Investigated DOSt Treatment Fate of 
blnation Organ' (mg/kg) Begins Graft TEC GC* DC TEC DC 
LEW kidney ++ + ++ +++ ++++ 
DA kidney ++ + ++ +++ ++++ 
DA->LEW DA kidney Rejected ++++ +++ +++ ++++ +++ 
DA .... LEW DA kidney 2.5 Day +1 Accepted +++ +++ 
DA->LEW DA kidney 2.5 Day +3 Accepted ++ +++ 
DA .... LEW DA kidney 2.5 Day +4 Rejected +/- +/- +/- ++++/++ +++ 
DA .... LEW DA kidney 2.5 Day +5 Rejected ++++/++ + ++ ++++ +++ 
DA .... LEW DA kidney 5.0 Day +5 Rejected ++++/++ + ++ ++++ +++ 
;Conventional immunoperoxidase histology of frozen donor kidney tissue sections on day + 6 postoperatively. 
TE DOS treatment: daily IP injections; monoclonal antibodies for MHC staining : MRC-OX18 for class I and MRC.QX6 for class 11. Abbreviations: DOS. 1S-deoxyspergualin. 
tC' tubular epithelial cells; GC. glomerular cells; DC. dendritic cells. - . no detectable reactivity ; +. very weak; + +. weak; + + +. strong; + + + +. very strong reactivity. 
GC are throughout negative in class 11. 
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medium) , as was shown in a direct IL-J assay using rat 
thymocytes as target cells. 
CONCLUSIONS 
I. Short-term DOS treatment may ImtIate long-standing 
specific tolerance, which even extends to skin grafts. 
WAAGA, ULRICHS, KRZYMANSKI ET AL 
2. DOS appears to interfere with antigen-presenting cells 
during the induction phase of allograft responses. 
3. DOS appears to reduce the expression of graft MHC 
class I antigens, ie, of major target antigens, when given 
within the first days after transplantation. 
